MedPath

The effect of anesthetic medications on the quality of electrocunvulsive therapy

Phase 3
Conditions
Condition 1: Major depression without psychotic feature. Condition 2: Major depression with psychotic feature.
Severe depressive episode without psychotic symptoms
Severe depressive episode with psychotic symptoms
??32.3
Registration Number
IRCT201306255026N3
Lead Sponsor
Vice chancellor for Research, Tehran university of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Major depression candidate for electroconvulsive therapy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart rate. Timepoint: before induction, 1, 3 and 10 minutes after induction. Method of measurement: ECG monitoring.;Blood pressure. Timepoint: before induction, 1, 3 and 10 minutes after induction. Method of measurement: mm Hg using noninvasive blood pressure monitoring.;Duration of seizure. Timepoint: after termination of seizure. Method of measurement: Chronometer.
Secondary Outcome Measures
NameTimeMethod
ausea. Timepoint: discharge from recovery. Method of measurement: direct question from patients and recording in data collection form.
© Copyright 2025. All Rights Reserved by MedPath